Suzanne Vernon: Difference between revisions
Notjusttired (talk | contribs) m (Text replacement - "first2=S" to " first2 = S") |
Notjusttired (talk | contribs) m (Text replacement - "|author-link5=" to " | authorlink5 = ") |
||
(17 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
[[File:SuzanneVernon.jpeg|right]] | [[File:SuzanneVernon.jpeg|right]] | ||
'''Suzanne D. Vernon''', PhD, is the Research Liaison at [[Bateman Horne Center]] of Excellence which specializes in treatment and research for [[ME/CFS]] and [[Fibromyalgia]]<ref name=":0">{{Cite web|url=https://batemanhornecenter.org/suzanne-d-vernon-phd/|title=Suzanne D. Vernon, PhD|website=Bateman Horne Center|language=en-US|access-date=2019-02-02}}</ref> and the Chief Scientific Revolutionary of The BioCollective, a collaborative that provides storage and sales of [[microbiome]] samples for research and development.<ref>http://www.thebiocollective.com/about-us/</ref> | '''Suzanne D. Vernon''', PhD, is the Research Liaison at [[Bateman Horne Center]] of Excellence which specializes in treatment and research for [[ME/CFS]] and [[Fibromyalgia]]<ref name=":0">{{Cite web|url=https://batemanhornecenter.org/suzanne-d-vernon-phd/ | title = Suzanne D. Vernon, PhD|website=Bateman Horne Center|language=en-US|access-date=2019-02-02}}</ref> and the Chief Scientific Revolutionary of The BioCollective, a collaborative that provides storage and sales of [[microbiome]] samples for research and development.<ref>http://www.thebiocollective.com/about-us/</ref> | ||
From November 2007 to May 2015, Dr. Vernon was the Scientific Director of [[Solve ME/CFS Initiative]], formerly known as CFIDS Association of America.<ref>{{Cite web|url=https://solvecfs.org/suzanne-d-vernon-steps-down-from-scientific-director-post/|title=Suzanne D. Vernon Steps Down from Scientific Director Post | date = 2015-04-08 | website = Solve ME/CFS Initiative|language=en-US|access-date=2019-02-02}}</ref> While there she recognized that access to well-characterized clinical populations was a barrier to engaging more scientists in ME/CFS research. Thus, she started the Research Institute Without Walls (RIWW), "the first nonprofit patient-centered research initiative focused on identifying diagnostic biomarkers and disease-modifying treatment for ME/CFS.<ref name=":0" /> The core of RIWW is the [[SolveCFS BioBank & Patient Registry]].<ref>{{Cite web|url=https://solvecfs.org/about-us/advancing-science-a-case-for-hope-a-look-ahead/|title=Advancing Science: A Case for Hope, A Look Ahead|website=Solve ME/CFS Initiative|language=en-US|access-date=2019-06-25}}</ref> | From November 2007 to May 2015, Dr. Vernon was the Scientific Director of [[Solve ME/CFS Initiative]], formerly known as CFIDS Association of America.<ref>{{Cite web|url=https://solvecfs.org/suzanne-d-vernon-steps-down-from-scientific-director-post/ | title = Suzanne D. Vernon Steps Down from Scientific Director Post | date = 2015-04-08 | website = Solve ME/CFS Initiative|language=en-US|access-date=2019-02-02}}</ref> While there she recognized that access to well-characterized clinical populations was a barrier to engaging more scientists in ME/CFS research. Thus, she started the Research Institute Without Walls (RIWW), "the first nonprofit patient-centered research initiative focused on identifying diagnostic biomarkers and disease-modifying treatment for ME/CFS.<ref name=":0" /> The core of RIWW is the [[SolveCFS BioBank & Patient Registry]].<ref>{{Cite web|url=https://solvecfs.org/about-us/advancing-science-a-case-for-hope-a-look-ahead/ | title = Advancing Science: A Case for Hope, A Look Ahead|website=Solve ME/CFS Initiative|language=en-US|access-date=2019-06-25}}</ref> | ||
From May 1990 to October 2007, Dr. Vernon worked for the US [[Centers for Disease Control]], first on the team investigating the human papillomavirus as an opportunistic infection in HIV-infected woman, and then in 1997, she became the CFS research group team leader, under [[William Reeves]], MD, the Director of the CDC Chronic Fatigue Research Program.<ref>https://www.linkedin.com/in/suzanne-d-vernon-phd-2743a617</ref><ref>{{Cite news|url=https://www.nytimes.com/2012/08/09/health/dr-william-c-reeves-who-sought-cause-of-fatigue-syndrome-dies-at-69.html|title=Dr. William C. Reeves, Who Sought Cause of Fatigue Syndrome, Dies at 69|last=Grady | first = Denise | date = 2012-08-08|work=The New York Times|access-date=2019-02-02|language=en-US|issn=0362-4331}}</ref> | From May 1990 to October 2007, Dr. Vernon worked for the US [[Centers for Disease Control]], first on the team investigating the human papillomavirus as an opportunistic infection in HIV-infected woman, and then in 1997, she became the CFS research group team leader, under [[William Reeves]], MD, the Director of the CDC Chronic Fatigue Research Program.<ref>https://www.linkedin.com/in/suzanne-d-vernon-phd-2743a617</ref><ref>{{Cite news | url=https://www.nytimes.com/2012/08/09/health/dr-william-c-reeves-who-sought-cause-of-fatigue-syndrome-dies-at-69.html | title = Dr. William C. Reeves, Who Sought Cause of Fatigue Syndrome, Dies at 69 | last = Grady | first = Denise | date = 2012-08-08|work=The New York Times|access-date=2019-02-02|language=en-US|issn=0362-4331}}</ref> | ||
In 2005, Dr Vernon was one of the authors of the [[Centers for Disease Control and Prevention|CDC]] case definition of [[Chronic fatigue syndrome|CFS]], commonly called the [[Reeves criteria]].<ref name=":1">{{Cite journal|last=Reeves | first=William C | | In 2005, Dr Vernon was one of the authors of the [[Centers for Disease Control and Prevention|CDC]] case definition of [[Chronic fatigue syndrome|CFS]], commonly called the [[Reeves criteria]].<ref name=":1">{{Cite journal | last = Reeves | first=William C | authorlink = William Reeves | last2 = Wagner | first2=Dieter | author-link2= | last3 = Nisenbaum | first3 = Rosane | author-link3= | last4 = Jones | first4=James F | authorlink4 = | last5 = Gurbaxani | first5 = Brian | author-link5= | last6 = Solomon | first6=Laura | author-link6= | last7 = Papanicolaou | first7 = Dimitris A | last8 = Unger | first8 = Elizabeth R | authorlink8 = Elizabeth Unger | last9 = Vernon | first9 = Suzanne D | authorlink9 = Suzanne Vernon | date = Dec 2005 | title = Chronic Fatigue Syndrome – A clinically empirical approach to its definition and study|url=http://bmcmedicine.biomedcentral.com/articles/10.1186/1741-7015-3-19|journal=BMC Medicine|language=en|volume=3|issue=|pages=19|doi=10.1186/1741-7015-3-19|issn=1741-7015|quote=|via=}}</ref> | ||
==Talks and interviews== | ==Talks and interviews== | ||
Line 16: | Line 16: | ||
==Studies and Articles== | ==Studies and Articles== | ||
*2003, Identification of ambiguities in the [[Fukuda criteria|1994 chronic fatigue syndrome research case definition]] and recommendations for resolution<ref name="Reeves,2003">{{Cite journal | last1 = Reeves | first1 = W.C. | authorlink = William Reeves | last2 = Lloyd | first2=A. | authorlink2 = Andrew Lloyd | last3 = Vernon | first3=S.D. | authorlink3 = Suzanne Vernon | last4 = Klimas | first4=N. | authorlink4 = Nancy Klimas | last5 = Jason | first5=L.A. | authorlink5 = Leonard Jason | last6 = Bleijenberg|first6=G. | authorlink6 = Gijs Bleijenberg | last7 = Evengard | first7=B. | authorlink7 = Birgitta Evengård | last8 = White | first8 = P.D. | authorlink8 = Peter White | last9 = Nisenbaum | first9 = R.|authorlink9=Rosane Nisenbaum | last10 = Unger | first10 = E.|authorlink10=Elizabeth Unger|title=Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution|journal=BMC Health Services Research|volume=3|issue=|pages=25|url=https://bmchealthservres.biomedcentral.com/articles/10.1186/1472-6963-3-25 | date = 2003|doi=10.1186/1472-6963-3-25}}</ref> - [https://bmchealthservres.biomedcentral.com/articles/10.1186/1472-6963-3-25 (Full Text)] | *2003, Identification of ambiguities in the [[Fukuda criteria|1994 chronic fatigue syndrome research case definition]] and recommendations for resolution<ref name="Reeves,2003">{{Cite journal | last1 = Reeves | first1 = W.C. | authorlink = William Reeves | last2 = Lloyd | first2=A. | authorlink2 = Andrew Lloyd | last3 = Vernon | first3=S.D. | authorlink3 = Suzanne Vernon | last4 = Klimas | first4 = N. | authorlink4 = Nancy Klimas | last5 = Jason | first5 = L.A. | authorlink5 = Leonard Jason | last6 = Bleijenberg | first6 = G. | authorlink6 = Gijs Bleijenberg | last7 = Evengard | first7=B. | authorlink7 = Birgitta Evengård | last8 = White | first8 = P.D. | authorlink8 = Peter White | last9 = Nisenbaum | first9 = R.|authorlink9=Rosane Nisenbaum | last10 = Unger | first10 = E.|authorlink10=Elizabeth Unger | title = Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution|journal=BMC Health Services Research|volume=3|issue=|pages=25|url=https://bmchealthservres.biomedcentral.com/articles/10.1186/1472-6963-3-25 | date = 2003|doi=10.1186/1472-6963-3-25}}</ref> - [https://bmchealthservres.biomedcentral.com/articles/10.1186/1472-6963-3-25 (Full Text)] | ||
*2003, Integration of [[gene expression]], clinical, and epidemiologic data to characterize Chronic Fatigue Syndrome<ref>{{Cite journal|last=Whistler | first=Toni | author-link=Toni Whistler | last2 = Unger | first2=Elizabeth R. | authorlink2 = Elizabeth Unger | last3 = Nisenbaum | first3 = Rosane | author-link3=Rosane Nisenbaum | last4 = Vernon | first4=Suzanne D. | authorlink4 = Suzanne Vernon | author-link5=|date=Dec 1, 2003|title=Integration of gene expression, clinical, and epidemiologic data to characterize Chronic Fatigue Syndrome|url=https://doi.org/10.1186/1479-5876-1-10|journal=Journal of Translational Medicine|volume=1|issue=|pages=10|doi=10.1186/1479-5876-1-10|issn=1479-5876|pmc=305360|pmid=14641939|quote=|via=}}</ref> - [https://doi.org/10.1186/1479-5876-1-10 (Full Text)] | *2003, Integration of [[gene expression]], clinical, and epidemiologic data to characterize Chronic Fatigue Syndrome<ref>{{Cite journal | last = Whistler | first=Toni | author-link=Toni Whistler | last2 = Unger | first2=Elizabeth R. | authorlink2 = Elizabeth Unger | last3 = Nisenbaum | first3 = Rosane | author-link3=Rosane Nisenbaum | last4 = Vernon | first4=Suzanne D. | authorlink4 = Suzanne Vernon | author-link5= | date = Dec 1, 2003 | title = Integration of gene expression, clinical, and epidemiologic data to characterize Chronic Fatigue Syndrome|url=https://doi.org/10.1186/1479-5876-1-10|journal=Journal of Translational Medicine|volume=1|issue=|pages=10|doi=10.1186/1479-5876-1-10|issn=1479-5876|pmc=305360|pmid=14641939|quote=|via=}}</ref> - [https://doi.org/10.1186/1479-5876-1-10 (Full Text)] | ||
*2004, Differential-display PCR of peripheral blood for biomarker discovery in chronic fatigue syndrome<ref>{{Cite journal|last=Rajeevan | first = Mangalathu S.|author-link=Mangalathu Rajeevan | last2 = Jones | first2=James F. | authorlink2 = | last3 = Vernon | first3=Suzanne D. | authorlink3 = Suzanne Vernon | last4 = Unger | first4=Elizabeth R. | authorlink4 = Elizabeth Unger | last5 = Steinau|first5=Martin | author-link5=|date=2004-11-01|title=Differential-display PCR of peripheral blood for biomarker discovery in chronic fatigue syndrome|url=https://link.springer.com/article/10.1007/s00109-004-0586-4|journal=Journal of Molecular Medicine|language=en|volume=82|issue=11 | pages = 750–755|doi=10.1007/s00109-004-0586-4|issn=1432-1440|quote=|via=}}</ref> - [[pubmed:15490094|(Abstract)]] | *2004, Differential-display PCR of peripheral blood for biomarker discovery in chronic fatigue syndrome<ref>{{Cite journal | last = Rajeevan | first = Mangalathu S.|author-link=Mangalathu Rajeevan | last2 = Jones | first2=James F. | authorlink2 = | last3 = Vernon | first3=Suzanne D. | authorlink3 = Suzanne Vernon | last4 = Unger | first4=Elizabeth R. | authorlink4 = Elizabeth Unger | last5 = Steinau | first5 = Martin | author-link5= | date = 2004-11-01 | title = Differential-display PCR of peripheral blood for biomarker discovery in chronic fatigue syndrome|url=https://link.springer.com/article/10.1007/s00109-004-0586-4|journal=Journal of Molecular Medicine|language=en|volume=82|issue=11 | pages = 750–755|doi=10.1007/s00109-004-0586-4|issn=1432-1440|quote=|via=}}</ref> - [[pubmed:15490094|(Abstract)]] | ||
*2005, [[Chronic Fatigue Syndrome]] – A clinically empirical approach to its definition and study<ref name=":1" /> | *2005, [[Chronic Fatigue Syndrome]] – A clinically empirical approach to its definition and study<ref name=":1" /> | ||
*2006, Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: Prospective cohort study<ref>{{Cite journal|last=Hickie | first = Ian | author-link=Ian Hickie | last2 = Davenport | first2=Tracey | authorlink2 = Tracey Davenport | last3 = Wakefield | first3=Denis|author-link3=Denis Wakefield | last4 = Vollmer-Conna | first4=Ute | authorlink4 = Uté Vollmer-Conna | last5 = Cameron | first5=Barbara | author-link5=Barbara Cameron | last6 = Vernon | first6=Suzanne D | authorlink6 = Suzanne Vernon | last7 = Reeves | first7=William C | authorlink7 = William Reeves | last8 = Lloyd | first8 = Andrew | authorlink8 = Andrew Lloyd|date=2006-09-16|title=Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study|url=http://www.bmj.com/lookup/doi/10.1136/bmj.38933.585764.AE|journal=BMJ|volume=333|issue=7568|pages=575–|doi=10.1136/bmj.38933.585764.ae|pmc=1569956|pmid=16950834|quote=|via=}}</ref> - [https://www.researchgate.net/publication/6838807_Post-infective_and_chronic_fatigue_syndromes_precipitated_by_viral_and_non-viral_pathogens_Prospective_cohort_study (Abstract)] | *2006, Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: Prospective cohort study<ref>{{Cite journal | last = Hickie | first = Ian | author-link=Ian Hickie | last2 = Davenport | first2=Tracey | authorlink2 = Tracey Davenport | last3 = Wakefield | first3=Denis|author-link3=Denis Wakefield | last4 = Vollmer-Conna | first4=Ute | authorlink4 = Uté Vollmer-Conna | last5 = Cameron | first5=Barbara | author-link5=Barbara Cameron | last6 = Vernon | first6=Suzanne D | authorlink6 = Suzanne Vernon | last7 = Reeves | first7=William C | authorlink7 = William Reeves | last8 = Lloyd | first8 = Andrew | authorlink8 = Andrew Lloyd | date = 2006-09-16 | title = Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study|url=http://www.bmj.com/lookup/doi/10.1136/bmj.38933.585764.AE|journal=BMJ|volume=333|issue=7568|pages=575–|doi=10.1136/bmj.38933.585764.ae|pmc=1569956|pmid=16950834|quote=|via=}}</ref> - [https://www.researchgate.net/publication/6838807_Post-infective_and_chronic_fatigue_syndromes_precipitated_by_viral_and_non-viral_pathogens_Prospective_cohort_study (Abstract)] | ||
*2006, Preliminary evidence of [[mitochondrion|mitochondrial]] dysfunction associated with post-infective fatigue after acute infection with Epstein Barr Virus<ref name="Vernon, 2006" /> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1373655/ (Full Text)] | *2006, Preliminary evidence of [[mitochondrion|mitochondrial]] dysfunction associated with post-infective fatigue after acute infection with Epstein Barr Virus<ref name="Vernon, 2006" /> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1373655/ (Full Text)] | ||
*2008, Neuroendocrine and immune network remodeling in chronic fatigue syndrome: an exploratory analysis<ref name="Fuite, 2010" /> - [https://www.sciencedirect.com/science/article/pii/S0888754308001948 (Full Text)] | *2008, Neuroendocrine and immune network remodeling in chronic fatigue syndrome: an exploratory analysis<ref name="Fuite, 2010" /> - [https://www.sciencedirect.com/science/article/pii/S0888754308001948 (Full Text)] | ||
*2008, Evidence of inflammatory immune signaling in [[chronic fatigue syndrome]]: A pilot study of gene expression in peripheral blood.<ref name="Aspler, 2008" /> - [http://psycnet.apa.org/record/2008-15631-001 (Abstract)] | *2008, Evidence of inflammatory immune signaling in [[chronic fatigue syndrome]]: A pilot study of gene expression in peripheral blood.<ref name="Aspler, 2008" /> - [http://psycnet.apa.org/record/2008-15631-001 (Abstract)] | ||
*2009, Transcriptional control of complement activation in an [[exercise]] model of [[chronic fatigue syndrome]]<ref>{{Cite journal|last=Sorensen | first = Bristol|author-link= | last2 = Jones | first2=James F | authorlink2 = | last3 = Vernon | first3=Suzanne D | authorlink3 = Suzanne Vernon | last4 = Rajeevan | first4=Mangalathu S | authorlink4 = Mangalathu Rajeevan | author-link5=|date=Jan 2009|title=Transcriptional Control of Complement Activation in an Exercise Model of Chronic Fatigue Syndrome|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2583111/|journal=Molecular Medicine|volume=15|issue=1-2|pages=34–42|doi=10.2119/molmed.2008.00098|pmc=2583111|pmid=19015737|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2583111/pdf/mol-15-34.pdf (Full text)] | *2009, Transcriptional control of complement activation in an [[exercise]] model of [[chronic fatigue syndrome]]<ref>{{Cite journal | last = Sorensen | first = Bristol | author-link= | last2 = Jones | first2=James F | authorlink2 = | last3 = Vernon | first3=Suzanne D | authorlink3 = Suzanne Vernon | last4 = Rajeevan | first4=Mangalathu S | authorlink4 = Mangalathu Rajeevan | author-link5= | date = Jan 2009 | title = Transcriptional Control of Complement Activation in an Exercise Model of Chronic Fatigue Syndrome|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2583111/|journal=Molecular Medicine|volume=15|issue=1-2|pages=34–42|doi=10.2119/molmed.2008.00098|pmc=2583111|pmid=19015737|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2583111/pdf/mol-15-34.pdf (Full text)] | ||
*2012, [[Cytokine]] expression profiles of immune imbalance in post-[[mononucleosis]] chronic fatigue<ref name="Broderick, 2012" /> - | *2012, [[Cytokine]] expression profiles of immune imbalance in post-[[mononucleosis]] chronic fatigue<ref name="Broderick, 2012" /> - | ||
*2014, No association found between the detection of either [[xenotropic murine leukemia virus-related virus]] or polytropic murine leukemia virus and [[chronic fatigue syndrome]] in a blinded, multi-site, prospective study by the establishment and use of the [[SolveCFS BioBank & Patient Registry|SolveCFS BioBank]]<ref>{{Cite journal|last=Irlbeck | first = David M. | last2 = Vernon | first2 = Suzanne D. | authorlink2 = Suzanne Vernon | last3 = McCleary | first3 = K. Kimberly|author-link3=Kim McCleary | last4 = Bateman | first4=Lucinda | authorlink4 = Lucinda Bateman | last5 = Klimas | first5=Nancy G.| | *2014, No association found between the detection of either [[xenotropic murine leukemia virus-related virus]] or polytropic murine leukemia virus and [[chronic fatigue syndrome]] in a blinded, multi-site, prospective study by the establishment and use of the [[SolveCFS BioBank & Patient Registry|SolveCFS BioBank]]<ref>{{Cite journal | last = Irlbeck | first = David M. | last2 = Vernon | first2 = Suzanne D. | authorlink2 = Suzanne Vernon | last3 = McCleary | first3 = K. Kimberly | author-link3=Kim McCleary | last4 = Bateman | first4 = Lucinda | authorlink4 = Lucinda Bateman | last5 = Klimas | first5=Nancy G. | authorlink5 = Nancy Klimas | last6 = Lapp | first6 = Charles W. | authorlink6 = Charles Lapp | last7 = Peterson | first7=Daniel L. | authorlink7 = Daniel Peterson | last8 = Brown | first8 = James R. | last9 = Remlinger | first9 = Katja S. | last10 = Wilfret | last11 = Gerondelis | first11 = Peter | first10 = David A. | date = 2014 | title=No association found between the detection of either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus and chronic fatigue syndrome in a blinded, multi-site, prospective study by the establishment and use of the SolveCFS BioBank | url =https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236736/|journal=BMC Research Notes|volume=7|pages=461|doi=10.1186/1756-0500-7-461|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236736/ (Full Text)] | ||
*2014, Examining case definition criteria for [[chronic fatigue syndrome]] and [[myalgic encephalomyelitis]]<ref name="Jason, LA, 2014" /> - | *2014, Examining case definition criteria for [[chronic fatigue syndrome]] and [[myalgic encephalomyelitis]]<ref name="Jason, LA, 2014" /> - | ||
*2015, [[Chronic fatigue syndrome]] versus [[Systemic Exertion Intolerance Disease|systemic exertion intolerance disease]]]<ref name="Jason, Sunn, 2015" /> - [http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1051291 (Abstract)] - | *2015, [[Chronic fatigue syndrome]] versus [[Systemic Exertion Intolerance Disease|systemic exertion intolerance disease]]]<ref name="Jason, Sunn, 2015" /> - [http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1051291 (Abstract)] - | ||
Line 32: | Line 32: | ||
*2015, Changes in Gut and Plasma [[Microbiome]] following [[Exercise]] Challenge in [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)]]<ref name="Shukla, 2015" /> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684203/ (Full Text)] | *2015, Changes in Gut and Plasma [[Microbiome]] following [[Exercise]] Challenge in [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)]]<ref name="Shukla, 2015" /> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684203/ (Full Text)] | ||
*2016, The utility of patient-reported outcome measures among patients with [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref name="Murdock, 2016">{{Cite journal | last1 = Murdock | first1 = KW | authorlink1 = | last2 = Wang | first2 = XS | authorlink2 = | last3 = Shi | first3 = Q| authorlink3 = | last4 = Cleeland | first4 = CS | authorlink4 = | last5 = Fagundes | first5 = CP | authorlink5 = | last6 = Vernon| first6 = Suzanne D. | authorlink6 = Suzanne Vernon| title = The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome.| journal = Quality of Life Research | volume = 26 | issue = | pages = 913–921 | date = 2016| pmid = 27600520 | pmc = PMC5336422 | doi = 10.1007/s11136-016-1406-3 | url = https://link.springer.com/article/10.1007/s11136-016-1406-3}}</ref> -[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336422/ (Full Text)] | *2016, The utility of patient-reported outcome measures among patients with [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref name="Murdock, 2016">{{Cite journal | last1 = Murdock | first1 = KW | authorlink1 = | last2 = Wang | first2 = XS | authorlink2 = | last3 = Shi | first3 = Q| authorlink3 = | last4 = Cleeland | first4 = CS | authorlink4 = | last5 = Fagundes | first5 = CP | authorlink5 = | last6 = Vernon| first6 = Suzanne D. | authorlink6 = Suzanne Vernon| title = The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome.| journal = Quality of Life Research | volume = 26 | issue = | pages = 913–921 | date = 2016| pmid = 27600520 | pmc = PMC5336422 | doi = 10.1007/s11136-016-1406-3 | url = https://link.springer.com/article/10.1007/s11136-016-1406-3}}</ref> -[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336422/ (Full Text)] | ||
*2016, Tracking post-infectious fatigue in clinic using routine Lab tests<ref name="Harvey2016">{{Cite journal|last=Harvey | first = Jeanna M.|author-link=Jeanna Harvey | last2 = Broderick | first2 = Gordon | author-link2=Gordon Broderick | last3 = Bowie | first3 = Alanna | author-link3=Alanna Bowie | last4 = Barnes | first4=Zachary M. | authorlink4 = Zachary Barnes | last5 = Katz|first5=Ben Z.| | *2016, Tracking post-infectious fatigue in clinic using routine Lab tests<ref name="Harvey2016">{{Cite journal | last = Harvey | first = Jeanna M.|author-link=Jeanna Harvey | last2 = Broderick | first2 = Gordon | author-link2=Gordon Broderick | last3 = Bowie | first3 = Alanna | author-link3=Alanna Bowie | last4 = Barnes | first4=Zachary M. | authorlink4 = Zachary Barnes | last5 = Katz | first5 = Ben Z. | authorlink5 = Ben Katz | last6 = O'Gorman | first6=Maurice R.G. |authorlink6 = Maurice O'Gorman | last7 = Vernon | first7=Suzanne D. | authorlink7 = Suzanne Vernon | last8 = Fletcher | first8 = Mary Ann | authorlink8 = Mary Ann Fletcher | last9 = Klimas | first9 = Nancy G. | authorlink9 = Nancy Klimas | date = 2016-04-26 | title = Tracking post-infectious fatigue in clinic using routine Lab tests|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847210/|journal=BMC Pediatrics|doi=10.1186/s12887-016-0596-8|issn=1471-2431|pmc=4847210|pmid=27118537|volume=15|issue=|pages=54|quote=}}</ref> - [https://bmcpediatr.biomedcentral.com/articles/10.1186/s12887-016-0596-8 (Full Text)] | ||
*2016, Current therapeutic strategies for [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]: results of an online survey<ref name="Deftereos, 2016" /> - [http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1126025 (Abstract)] | *2016, Current therapeutic strategies for [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]: results of an online survey<ref name="Deftereos, 2016" /> - [http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1126025 (Abstract)] | ||
*2016, Article - [https://batemanhornecenter.org/uncovering-biomarkers-fcg-receptors/ Uncovering Biomarkers– Fcg receptors in ME/CFS] | *2016, Article - [https://batemanhornecenter.org/uncovering-biomarkers-fcg-receptors/ Uncovering Biomarkers– Fcg receptors in ME/CFS] | ||
*2016, Reductions in circulating levels of [[interleukin 16|IL-16]], [[interleukin 7|IL-7]] and [[VEGF]]-A in [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref>{{Cite journal|last=Landi | first = Abdolamir | author-link=Amir Landi | last2 = Broadhurst | first2=David | author-link2= | last3 = Vernon | first3=Suzanne D. | authorlink3 = Suzanne Vernon | last4 = Tyrrell | first4 = D. Lorne J. | authorlink4 = | last5 = Houghton | first5=Michael|author-link5=Michael Houghton|date=Feb 2016|title=Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome|url=https://linkinghub.elsevier.com/retrieve/pii/S1043466615301071|journal=Cytokine|language=en|volume=78|issue=|pages=27–36|doi=10.1016/j.cyto.2015.11.018|quote=|via=}}</ref> - [http://www.sciencedirect.com/science/article/pii/S1043466615301071 (Full Text)] | *2016, Reductions in circulating levels of [[interleukin 16|IL-16]], [[interleukin 7|IL-7]] and [[VEGF]]-A in [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref>{{Cite journal | last = Landi | first = Abdolamir | author-link=Amir Landi | last2 = Broadhurst | first2=David | author-link2= | last3 = Vernon | first3=Suzanne D. | authorlink3 = Suzanne Vernon | last4 = Tyrrell | first4 = D. Lorne J. | authorlink4 = | last5 = Houghton | first5=Michael | author-link5=Michael Houghton | date = Feb 2016 | title = Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome|url=https://linkinghub.elsevier.com/retrieve/pii/S1043466615301071|journal=Cytokine|language=en|volume=78|issue=|pages=27–36|doi=10.1016/j.cyto.2015.11.018|quote=|via=}}</ref> - [http://www.sciencedirect.com/science/article/pii/S1043466615301071 (Full Text)] | ||
*2017, Epigenetic modifications and glucocorticoid sensitivity in [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)]]<ref name="de Vega, 2017" /> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324230/ (Full Text)] | *2017, Epigenetic modifications and glucocorticoid sensitivity in [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)]]<ref name="de Vega, 2017" /> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324230/ (Full Text)] | ||
*2017, Neural Consequences of [[post-exertional malaise|Post-Exertion Malaise]] in [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome]]<ref name="Cook, 2017" /> - [https://www.sciencedirect.com/science/article/pii/S088915911730051X?via%3Dihub (Full Text)] - | *2017, Neural Consequences of [[post-exertional malaise|Post-Exertion Malaise]] in [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome]]<ref name="Cook, 2017" /> - [https://www.sciencedirect.com/science/article/pii/S088915911730051X?via%3Dihub (Full Text)] - | ||
Line 41: | Line 41: | ||
*2018, Integration of DNA methylation & health scores identifies subtypes in [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref name="de Vega, 2018">{{Cite journal | last1 = de Vega | first1 = Wilfred C. | authorlink1 = Wilfred de Vega | last2 = Erdman | first2 = Lauren | authorlink2 = | last3 = Vernon | first3 = Suzanne D. | authorlink3 = Suzanne Vernon | last4 = Goldenberg | first4 = Anna | authorlink4 = | last5 = McGowan | first5 = Patrick O. | authorlink5 = Patrick McGowan| title = Integration of DNA methylation & health scores identifies subtypes in myalgic encephalomyelitis/chronic fatigue syndrome| journal = Epigenomics | volume = 10 | issue = 5 | pages = 539-557 | date = 2018| url = https://www.futuremedicine.com/doi/10.2217/epi-2017-0150 | pmid = | pmc = | doi = 10.2217/epi-2017-0150}}</ref> - [https://www.futuremedicine.com/doi/10.2217/epi-2017-0150 (Abstract)] | *2018, Integration of DNA methylation & health scores identifies subtypes in [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref name="de Vega, 2018">{{Cite journal | last1 = de Vega | first1 = Wilfred C. | authorlink1 = Wilfred de Vega | last2 = Erdman | first2 = Lauren | authorlink2 = | last3 = Vernon | first3 = Suzanne D. | authorlink3 = Suzanne Vernon | last4 = Goldenberg | first4 = Anna | authorlink4 = | last5 = McGowan | first5 = Patrick O. | authorlink5 = Patrick McGowan| title = Integration of DNA methylation & health scores identifies subtypes in myalgic encephalomyelitis/chronic fatigue syndrome| journal = Epigenomics | volume = 10 | issue = 5 | pages = 539-557 | date = 2018| url = https://www.futuremedicine.com/doi/10.2217/epi-2017-0150 | pmid = | pmc = | doi = 10.2217/epi-2017-0150}}</ref> - [https://www.futuremedicine.com/doi/10.2217/epi-2017-0150 (Abstract)] | ||
*2018, Letter - Markers of non-coeliac wheat sensitivity in patients with [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref name="Uhde, 2018" /> - [http://gut.bmj.com/content/early/2018/03/17/gutjnl-2018-316133.long (Full Text)] | *2018, Letter - Markers of non-coeliac wheat sensitivity in patients with [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref name="Uhde, 2018" /> - [http://gut.bmj.com/content/early/2018/03/17/gutjnl-2018-316133.long (Full Text)] | ||
*2018, Genome-epigenome interactions associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome<ref>{{Cite journal|last=Herrera | first=S | | *2018, Genome-epigenome interactions associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome<ref>{{Cite journal | last = Herrera | first = S | authorlink = | last2 = de Vega | first2=WC | authorlink2 = Wilfred de Vega | last3 = Ashbrook | first3 = D | authorlink3 = | last4 = Vernon | first4=SD | authorlink4 = Suzanne Vernon | last5 = McGowan | first5=PO | authorlink5 = Patrick McGowan | date = Dec 2018 | title = Genome-epigenome interactions associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome|journal=Epigenetics|volume=13|issue=12|pages=1174-1190| url = https://www.ncbi.nlm.nih.gov/pubmed/30516085 | pmid = 30516085 |doi=10.1080/15592294.2018.1549769|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pubmed/30516085 (Abstract)] | ||
*2019, Perturbation of effector and regulatory [[T cell]] subsets in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)<ref>{{Cite journal | last = Karhan | first = Ece | last2 = Gunter | first2=Courtney L | last3 = Ravanmehr | first3=Vida | last4 = Horne | first4 = Meghan | last5 = Kozhaya | first5=Lina | last6 = Renzullo|first6=Stephanie | last7 = Placek|first7=Lindsey | last8 = George | first8 = Joshy | last9 = Robinson | first9 = Peter N | last10 = Vernon | first10 = Suzanne D. | authorlink10 = Suzanne Vernon | last11 = Bateman | first11 = Lucinda | authorlink11 = Lucinda Bateman | last12 = Unutmaz | first12 = Derya | authorlink12 = Derya Unutmaz|date=2019-12-26|title=Perturbation of effector and regulatory T cell subsets in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)|journal=biorxiv|url=http://biorxiv.org/lookup/doi/10.1101/2019.12.23.887505|doi=10.1101/2019.12.23.887505}}</ref> - [https://www.biorxiv.org/content/10.1101/2019.12.23.887505v1.full (Full text)] | *2019, Perturbation of effector and regulatory [[T cell]] subsets in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)<ref>{{Cite journal | last = Karhan | first = Ece | last2 = Gunter | first2=Courtney L | last3 = Ravanmehr | first3=Vida | last4 = Horne | first4 = Meghan | last5 = Kozhaya | first5 = Lina | last6 = Renzullo | first6 = Stephanie | last7 = Placek| first7 = Lindsey | last8 = George | first8 = Joshy | last9 = Robinson | first9 = Peter N | last10 = Vernon | first10 = Suzanne D. | authorlink10 = Suzanne Vernon | last11 = Bateman | first11 = Lucinda | authorlink11 = Lucinda Bateman | last12 = Unutmaz | first12 = Derya | authorlink12 = Derya Unutmaz | date = 2019-12-26 | title = Perturbation of effector and regulatory T cell subsets in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)|journal=biorxiv|url=http://biorxiv.org/lookup/doi/10.1101/2019.12.23.887505|doi=10.1101/2019.12.23.887505}}</ref> - [https://www.biorxiv.org/content/10.1101/2019.12.23.887505v1.full (Full text)] | ||
*2020, Hemodynamics during the 10-minute NASA Lean Test: evidence of circulatory decompensation in a subset of ME/CFS patients<ref>{{Cite journal|last=Lee | first = Jihyun | author-link= | last2 = Vernon | first2 = Suzanne D. | authorlink2 = Suzanne Vernon | last3 = Jeys | first3=Patricia | author-link3= | last4 = Ali | first4 = Weam | authorlink4 = | last5 = Campos | first5=Andrea | author-link5= | last6 = Unutmaz|first6=Derya | author-link6=Derya Unutmaz | last7 = Yellman | first7=Brayden | last8 = Bateman | first8 = Lucinda | authorlink8 = Lucinda Bateman|date=Dec 2020|title=Hemodynamics during the 10-minute NASA Lean Test: evidence of circulatory decompensation in a subset of ME/CFS patients|url=https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-020-02481-y|journal=Journal of Translational Medicine|language=en|volume=18|issue=1|pages=314|doi=10.1186/s12967-020-02481-y|issn=1479-5876|pmc = 7429890|pmid=32799889|access-date=|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429890/ (Full text)] | *2020, Hemodynamics during the 10-minute NASA Lean Test: evidence of circulatory decompensation in a subset of ME/CFS patients<ref>{{Cite journal | last = Lee | first = Jihyun | author-link= | last2 = Vernon | first2 = Suzanne D. | authorlink2 = Suzanne Vernon | last3 = Jeys | first3=Patricia | author-link3= | last4 = Ali | first4 = Weam | authorlink4 = | last5 = Campos | first5=Andrea | author-link5= | last6 = Unutmaz | first6 = Derya | author-link6=Derya Unutmaz | last7 = Yellman | first7=Brayden | last8 = Bateman | first8 = Lucinda | authorlink8 = Lucinda Bateman | date = Dec 2020 | title = Hemodynamics during the 10-minute NASA Lean Test: evidence of circulatory decompensation in a subset of ME/CFS patients|url=https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-020-02481-y|journal=Journal of Translational Medicine|language=en|volume=18|issue=1|pages=314|doi=10.1186/s12967-020-02481-y|issn=1479-5876|pmc = 7429890|pmid=32799889|access-date=|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429890/ (Full text)] | ||
==Online presence== | ==Online presence== | ||
Line 62: | Line 62: | ||
| doi = 10.1186/1479-5876-10-191}}</ref> | | doi = 10.1186/1479-5876-10-191}}</ref> | ||
<ref name="Cook, 2017">{{Cite journal | last1 = Cook | first1 = Dane B. | authorlink1 = Dane Cook | last2 = Light | first2 = Alan R. | authorlink2 = Alan Light | last3 = Light | first3 = Kathleen C. | authorlink3 = Kathleen Light | last4 = Broderick | first4 = Gordon | authorlink4 = Gordon Broderick | last5 = Shields | first5 = Morgan R. | authorlink5 = | last6 = Dougherty | first6 = Ryan J. | authorlink6 = | last7 = Meyer | first7 = Jacob D. | authorlink7 = | last8 = VanRiper | first8 = Stephanie | authorlink8 = | last9 = Stegner | first9 = Aaron J. | authorlink9 = | last10 = Ellingson | first10 = Laura D. | authorlink10 = | last11 = Vernon | first11 = Suzanne D. | authorlink11 = Suzanne Vernon | title = Neural Consequences of Post-Exertion Malaise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome| journal = Brain, Behavior, and Immunity | volume = 62 | issue = | pages =87-99 | url = https://www.sciencedirect.com/science/article/pii/S088915911730051X | date = 2017| pmid = | doi = 10.1016/j.bbi.2017.02.009}}</ref> | <ref name="Cook, 2017">{{Cite journal | last1 = Cook | first1 = Dane B. | authorlink1 = Dane Cook | last2 = Light | first2 = Alan R. | authorlink2 = Alan Light | last3 = Light | first3 = Kathleen C. | authorlink3 = Kathleen Light | last4 = Broderick | first4 = Gordon | authorlink4 = Gordon Broderick | last5 = Shields | first5 = Morgan R. | authorlink5 = | last6 = Dougherty | first6 = Ryan J. | authorlink6 = | last7 = Meyer | first7 = Jacob D. | authorlink7 = | last8 = VanRiper | first8 = Stephanie | authorlink8 = | last9 = Stegner | first9 = Aaron J. | authorlink9 = | last10 = Ellingson | first10 = Laura D. | authorlink10 = | last11 = Vernon | first11 = Suzanne D. | authorlink11 = Suzanne Vernon | title = Neural Consequences of Post-Exertion Malaise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome| journal = Brain, Behavior, and Immunity | volume = 62 | issue = | pages =87-99 | url = https://www.sciencedirect.com/science/article/pii/S088915911730051X | date = 2017| pmid = | doi = 10.1016/j.bbi.2017.02.009}}</ref> | ||
<ref name="Deftereos, 2016">{{Cite journal | last1 = Deftereos | first1 = S. N. | authorlink1 = | last2 = Vernon | first2 = S. D. | authorlink2 = Suzanne Vernon | last3 = Persidis | first3 = A.| authorlink3 = | title = Current therapeutic strategies for myalgic encephalomyelitis/chronic fatigue syndrome: results of an online survey| journal = Fatigue: Biomedicine, Health & Behavior | volume = 4 | issue = 1 | pages = 39-51 | url = http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1126025 | date = 2016| pmid = | doi = 10.1080/21641846.2015.1126025}}</ref> | <ref name="Deftereos, 2016">{{Cite journal | last1 = Deftereos | first1 = S. N. | authorlink1 = | last2 = Vernon | first2 = S. D. | authorlink2 = Suzanne Vernon | last3 = Persidis | first3 = A. | authorlink3 = | title = Current therapeutic strategies for myalgic encephalomyelitis/chronic fatigue syndrome: results of an online survey| journal = Fatigue: Biomedicine, Health & Behavior | volume = 4 | issue = 1 | pages = 39-51 | url = http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1126025 | date = 2016| pmid = | doi = 10.1080/21641846.2015.1126025}}</ref> | ||
<ref name="de Vega, 2017">{{Cite journal | last1 = de Vega | first1 = Wilfred C. | authorlink1 = Wilfred de Vega | last2 = Herrera | first2 = Santiago | authorlink2 = | last3 = Vernon | first3 = Suzanne D. | authorlink3 = Suzanne Vernon | last4 = McGowan | first4 = Patrick O. | authorlink4 = Patrick McGowan| title = Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)| journal = BMC Med Genomics | volume = 10 | issue = | pages = 11 | url = https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324230/ | date = 2017 | <ref name="de Vega, 2017">{{Cite journal | last1 = de Vega | first1 = Wilfred C. | authorlink1 = Wilfred de Vega | last2 = Herrera | first2 = Santiago | authorlink2 = | last3 = Vernon | first3 = Suzanne D. | authorlink3 = Suzanne Vernon | last4 = McGowan | first4 = Patrick O. | authorlink4 = Patrick McGowan| title = Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)| journal = BMC Med Genomics | volume = 10 | issue = | pages = 11 | url = https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324230/ | date = 2017 | ||
| pmid = | pmc = PMC5324230 | doi = 10.1186/s12920-017-0248-3}}</ref> | | pmid = | pmc = PMC5324230 | doi = 10.1186/s12920-017-0248-3}}</ref> |
Revision as of 23:12, November 30, 2022
Suzanne D. Vernon, PhD, is the Research Liaison at Bateman Horne Center of Excellence which specializes in treatment and research for ME/CFS and Fibromyalgia[1] and the Chief Scientific Revolutionary of The BioCollective, a collaborative that provides storage and sales of microbiome samples for research and development.[2]
From November 2007 to May 2015, Dr. Vernon was the Scientific Director of Solve ME/CFS Initiative, formerly known as CFIDS Association of America.[3] While there she recognized that access to well-characterized clinical populations was a barrier to engaging more scientists in ME/CFS research. Thus, she started the Research Institute Without Walls (RIWW), "the first nonprofit patient-centered research initiative focused on identifying diagnostic biomarkers and disease-modifying treatment for ME/CFS.[1] The core of RIWW is the SolveCFS BioBank & Patient Registry.[4]
From May 1990 to October 2007, Dr. Vernon worked for the US Centers for Disease Control, first on the team investigating the human papillomavirus as an opportunistic infection in HIV-infected woman, and then in 1997, she became the CFS research group team leader, under William Reeves, MD, the Director of the CDC Chronic Fatigue Research Program.[5][6]
In 2005, Dr Vernon was one of the authors of the CDC case definition of CFS, commonly called the Reeves criteria.[7]
Talks and interviews[edit | edit source]
- 2012, "Cognition & CFS: What Do We Know?" by the CFIDS Association of America with speakers Gudrun Lange and Suzanne Vernon, introduced by Kim McCleary
- 2014, Episode 70, ME/CFS Alert - Llewellyn King Interviews Dr. Suzanne Vernon
- 2015, Sleep and ME/CFS - Suzanne Vernon, PhD, A Bateman Horne Education Meeting
- 2015, [1]Spoonie Radio Episode 09 Guest - Dr. Suzanne Vernon Podcast and Full Text Transcript
- 2016, Precision Medicine for ME/CFS & Fibromyalgia
Studies and Articles[edit | edit source]
- 2003, Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution[8] - (Full Text)
- 2003, Integration of gene expression, clinical, and epidemiologic data to characterize Chronic Fatigue Syndrome[9] - (Full Text)
- 2004, Differential-display PCR of peripheral blood for biomarker discovery in chronic fatigue syndrome[10] - (Abstract)
- 2005, Chronic Fatigue Syndrome – A clinically empirical approach to its definition and study[7]
- 2006, Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: Prospective cohort study[11] - (Abstract)
- 2006, Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr Virus[12] - (Full Text)
- 2008, Neuroendocrine and immune network remodeling in chronic fatigue syndrome: an exploratory analysis[13] - (Full Text)
- 2008, Evidence of inflammatory immune signaling in chronic fatigue syndrome: A pilot study of gene expression in peripheral blood.[14] - (Abstract)
- 2009, Transcriptional control of complement activation in an exercise model of chronic fatigue syndrome[15] - (Full text)
- 2012, Cytokine expression profiles of immune imbalance in post-mononucleosis chronic fatigue[16] -
- 2014, No association found between the detection of either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus and chronic fatigue syndrome in a blinded, multi-site, prospective study by the establishment and use of the SolveCFS BioBank[17] - (Full Text)
- 2014, Examining case definition criteria for chronic fatigue syndrome and myalgic encephalomyelitis[18] -
- 2015, Chronic fatigue syndrome versus systemic exertion intolerance disease][19] - (Abstract) -
- 2015, Comparing and contrasting consensus versus empirical domains[20] - (Abstract) -
- 2015, Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)[21] - (Full Text)
- 2016, The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome[22] -(Full Text)
- 2016, Tracking post-infectious fatigue in clinic using routine Lab tests[23] - (Full Text)
- 2016, Current therapeutic strategies for myalgic encephalomyelitis/chronic fatigue syndrome: results of an online survey[24] - (Abstract)
- 2016, Article - Uncovering Biomarkers– Fcg receptors in ME/CFS
- 2016, Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome[25] - (Full Text)
- 2017, Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)[26] - (Full Text)
- 2017, Neural Consequences of Post-Exertion Malaise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome[27] - (Full Text) -
- 2018, A C-reactive protein response in patients with post-treatment Lyme Disease symptoms versus those with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome[28] - (Abstract)
- 2018, Integration of DNA methylation & health scores identifies subtypes in myalgic encephalomyelitis/chronic fatigue syndrome[29] - (Abstract)
- 2018, Letter - Markers of non-coeliac wheat sensitivity in patients with myalgic encephalomyelitis/chronic fatigue syndrome[30] - (Full Text)
- 2018, Genome-epigenome interactions associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome[31] - (Abstract)
- 2019, Perturbation of effector and regulatory T cell subsets in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)[32] - (Full text)
- 2020, Hemodynamics during the 10-minute NASA Lean Test: evidence of circulatory decompensation in a subset of ME/CFS patients[33] - (Full text)
Online presence[edit | edit source]
Learn more[edit | edit source]
See also[edit | edit source]
References[edit | edit source]
- ↑ 1.0 1.1 "Suzanne D. Vernon, PhD". Bateman Horne Center. Retrieved February 2, 2019.
- ↑ http://www.thebiocollective.com/about-us/
- ↑ "Suzanne D. Vernon Steps Down from Scientific Director Post". Solve ME/CFS Initiative. April 8, 2015. Retrieved February 2, 2019.
- ↑ "Advancing Science: A Case for Hope, A Look Ahead". Solve ME/CFS Initiative. Retrieved June 25, 2019.
- ↑ https://www.linkedin.com/in/suzanne-d-vernon-phd-2743a617
- ↑ Grady, Denise (August 8, 2012). "Dr. William C. Reeves, Who Sought Cause of Fatigue Syndrome, Dies at 69". The New York Times. ISSN 0362-4331. Retrieved February 2, 2019.
- ↑ 7.0 7.1 Reeves, William C; Wagner, Dieter; Nisenbaum, Rosane; Jones, James F; Gurbaxani, Brian; Solomon, Laura; Papanicolaou, Dimitris A; Unger, Elizabeth R; Vernon, Suzanne D (December 2005). "Chronic Fatigue Syndrome – A clinically empirical approach to its definition and study". BMC Medicine. 3: 19. doi:10.1186/1741-7015-3-19. ISSN 1741-7015.
- ↑ Reeves, W.C.; Lloyd, A.; Vernon, S.D.; Klimas, N.; Jason, L.A.; Bleijenberg, G.; Evengard, B.; White, P.D.; Nisenbaum, R.; Unger, E. (2003). "Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution". BMC Health Services Research. 3: 25. doi:10.1186/1472-6963-3-25.
- ↑ Whistler, Toni; Unger, Elizabeth R.; Nisenbaum, Rosane; Vernon, Suzanne D. (December 1, 2003). "Integration of gene expression, clinical, and epidemiologic data to characterize Chronic Fatigue Syndrome". Journal of Translational Medicine. 1: 10. doi:10.1186/1479-5876-1-10. ISSN 1479-5876. PMC 305360. PMID 14641939.
- ↑ Rajeevan, Mangalathu S.; Jones, James F.; Vernon, Suzanne D.; Unger, Elizabeth R.; Steinau, Martin (November 1, 2004). "Differential-display PCR of peripheral blood for biomarker discovery in chronic fatigue syndrome". Journal of Molecular Medicine. 82 (11): 750–755. doi:10.1007/s00109-004-0586-4. ISSN 1432-1440.
- ↑ Hickie, Ian; Davenport, Tracey; Wakefield, Denis; Vollmer-Conna, Ute; Cameron, Barbara; Vernon, Suzanne D; Reeves, William C; Lloyd, Andrew (September 16, 2006). "Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study". BMJ. 333 (7568): 575–. doi:10.1136/bmj.38933.585764.ae. PMC 1569956. PMID 16950834.
- ↑ Vernon, SD; Whistler, T; Cameron, B; Hickie, IB; Reeves, WC; Lloyd, A (2006). "Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr Virus". BMC Infectious Diseases. 6 (15). doi:10.1186/1471-2334-6-15. PMID 16448567.
- ↑ Fuite, Jim; Vernon, Suzanne; Broderick, Gordon (2008). "Neuroendocrine and immune network re-modeling in chronic fatigue syndrome: an exploratory analysis". Genomics. 92 (6): 393–9. doi:10.1016/j.ygeno.2008.08.008. PMID 18775774.
- ↑ Aspler, AL; Bolshin, C; Vernon, SD; Broderick, G (2008). "Evidence of inflammatory immune signaling in chronic fatigue syndrome: A pilot study of gene expression in peripheral blood". Behavioral and Brain Functions. 4: 44. doi:10.1186/1744-9081-4-44.
- ↑ Sorensen, Bristol; Jones, James F; Vernon, Suzanne D; Rajeevan, Mangalathu S (January 2009). "Transcriptional Control of Complement Activation in an Exercise Model of Chronic Fatigue Syndrome". Molecular Medicine. 15 (1–2): 34–42. doi:10.2119/molmed.2008.00098. PMC 2583111. PMID 19015737.
- ↑ Broderick, Gordon; Katz, Ben Z; Fernandes, Henrique; Fletcher, Mary Ann; Klimas, Nancy; Smith, Frederick A; O'Gorman, Maurice RG; Vernon, Suzanne D; Taylor, Renee (2012). "Cytokine expression profiles of immune imbalance in post-mononucleosis chronic fatigue". Journal of Translational Medicine. 10: 191. doi:10.1186/1479-5876-10-191.
- ↑ Irlbeck, David M.; Vernon, Suzanne D.; McCleary, K. Kimberly; Bateman, Lucinda; Klimas, Nancy G.; Lapp, Charles W.; Peterson, Daniel L.; Brown, James R.; Remlinger, Katja S.; Wilfret, David A.; Gerondelis, Peter (2014). "No association found between the detection of either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus and chronic fatigue syndrome in a blinded, multi-site, prospective study by the establishment and use of the SolveCFS BioBank". BMC Research Notes. 7: 461. doi:10.1186/1756-0500-7-461.
- ↑ Jason, Leonard A.; Sunnquist, Madison; Brown, Abigail; Evans, Meredyth; Vernon, Suzanne D.; Furst, Jacob D.; Simonis, Valerie (2014). "Examining case definition criteria for chronic fatigue syndrome and myalgic encephalomyelitis". Fatigue: Biomedicine, Health & Behavior. 2 (1): 40–56. doi:10.1080/21641846.2013.862993. PMC 3912876.
- ↑ Jason, L.A.; Sunnquist, M.; Brown, A.; Newton, J.L.; Strand, E.B.; Vernon, S.D. (2015). "Chronic fatigue syndrome versus systemic exertion intolerance disease". Fatigue: Biomedicine, Health & Behavior. 3 (3): 127–141. doi:10.1080/21641846.2015.1051291.
- ↑ Jason, LA; Kot, B; Sunnquist, M; Brown, A; Reed, J; Furst, J; Newton, JL; Strand, EB; Vernon, SD (2015). "Comparing and Contrasting Consensus versus Empirical Domains". Fatigue: biomedicine, health & behavior. 3 (2): 63–74. doi:10.1080/21641846.2015.1017344. PMID 26977374.
- ↑ Shukla, SK; Cook, DB; Meyer, J; Vernon, SD; Le, T; Clevidence, D; Robertson, CE; Schrodi, SJ; Yale, S; Frank, DN (2015). "Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)". PLoS One. 10 (12): e0145453. doi:10.1371/journal.pone.0145453. PMC 468420.
- ↑ Murdock, KW; Wang, XS; Shi, Q; Cleeland, CS; Fagundes, CP; Vernon, Suzanne D. (2016). "The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome". Quality of Life Research. 26: 913–921. doi:10.1007/s11136-016-1406-3. PMC 5336422. PMID 27600520.
- ↑ Harvey, Jeanna M.; Broderick, Gordon; Bowie, Alanna; Barnes, Zachary M.; Katz, Ben Z.; O'Gorman, Maurice R.G.; Vernon, Suzanne D.; Fletcher, Mary Ann; Klimas, Nancy G. (April 26, 2016). "Tracking post-infectious fatigue in clinic using routine Lab tests". BMC Pediatrics. 15: 54. doi:10.1186/s12887-016-0596-8. ISSN 1471-2431. PMC 4847210. PMID 27118537.
- ↑ Deftereos, S. N.; Vernon, S. D.; Persidis, A. (2016). "Current therapeutic strategies for myalgic encephalomyelitis/chronic fatigue syndrome: results of an online survey". Fatigue: Biomedicine, Health & Behavior. 4 (1): 39–51. doi:10.1080/21641846.2015.1126025.
- ↑ Landi, Abdolamir; Broadhurst, David; Vernon, Suzanne D.; Tyrrell, D. Lorne J.; Houghton, Michael (February 2016). "Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome". Cytokine. 78: 27–36. doi:10.1016/j.cyto.2015.11.018.
- ↑ de Vega, Wilfred C.; Herrera, Santiago; Vernon, Suzanne D.; McGowan, Patrick O. (2017). "Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)". BMC Med Genomics. 10: 11. doi:10.1186/s12920-017-0248-3. PMC 5324230.
- ↑ Cook, Dane B.; Light, Alan R.; Light, Kathleen C.; Broderick, Gordon; Shields, Morgan R.; Dougherty, Ryan J.; Meyer, Jacob D.; VanRiper, Stephanie; Stegner, Aaron J.; Ellingson, Laura D.; Vernon, Suzanne D. (2017). "Neural Consequences of Post-Exertion Malaise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Brain, Behavior, and Immunity. 62: 87–99. doi:10.1016/j.bbi.2017.02.009.
- ↑ Uhde, M; Indart, AC; Fallon, BA; Wormser, GP; Marques, AR; Vernon, SD; Alaedini, A (2018). "C-reactive protein response in patients with post-treatment Lyme Disease symptoms versus those with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Clin Infect Dis. 67 (8): 1309–1310. doi:10.1093/cid/ciy299. PMC 6160605. PMID 29741589.
- ↑ de Vega, Wilfred C.; Erdman, Lauren; Vernon, Suzanne D.; Goldenberg, Anna; McGowan, Patrick O. (2018). "Integration of DNA methylation & health scores identifies subtypes in myalgic encephalomyelitis/chronic fatigue syndrome". Epigenomics. 10 (5): 539–557. doi:10.2217/epi-2017-0150.
- ↑ Uhde, M; Indart, AC; Yu, XB; Jang, SS; De Giorgio, R; Green, PHR; Volta, U; Vernon, SD; Alaedini, A (2018). "Markers of non-coeliac wheat sensitivity in patients with myalgic encephalomyelitis/chronic fatigue syndrome". Gut. 68: 377–378. doi:10.1136/gutjnl-2018-316133.
- ↑ Herrera, S; de Vega, WC; Ashbrook, D; Vernon, SD; McGowan, PO (December 2018). "Genome-epigenome interactions associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Epigenetics. 13 (12): 1174–1190. doi:10.1080/15592294.2018.1549769. PMID 30516085.
- ↑ Karhan, Ece; Gunter, Courtney L; Ravanmehr, Vida; Horne, Meghan; Kozhaya, Lina; Renzullo, Stephanie; Placek, Lindsey; George, Joshy; Robinson, Peter N; Vernon, Suzanne D.; Bateman, Lucinda; Unutmaz, Derya (December 26, 2019). "Perturbation of effector and regulatory T cell subsets in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)". biorxiv. doi:10.1101/2019.12.23.887505.
- ↑ Lee, Jihyun; Vernon, Suzanne D.; Jeys, Patricia; Ali, Weam; Campos, Andrea; Unutmaz, Derya; Yellman, Brayden; Bateman, Lucinda (December 2020). "Hemodynamics during the 10-minute NASA Lean Test: evidence of circulatory decompensation in a subset of ME/CFS patients". Journal of Translational Medicine. 18 (1): 314. doi:10.1186/s12967-020-02481-y. ISSN 1479-5876. PMC 7429890. PMID 32799889.